Trial pipeline
Track psilocybin trial phases, recruitment, sponsors and registry completion dates with country filters, source links, comparison and free data exports.
Free access · No subscription for research tools or data exports
Filter the development pipeline
9 trials match this view; 7 reported facilities; 7 have usable coordinates. Latest indexed registry check Nov 19, 2026 02:23 UTC. Country membership uses reported locations, including locations without coordinates; Mapped-facility counts cover all sites of matching trials, including international sites, and require valid coordinates.
Enrollment sum: 318 across 9 records with a reported count. Planned and actual counts are mixed; this is not a count of unique treated participants.
Recorded study-start years
Current indexed registry status
Reported research conditions
Counts describe indexed registry records, not efficacy or total research activity. A trial can count under several conditions or countries. Unknown dates are excluded from the start-year chart; future years reflect planned starts. Stopped studies may reflect recruitment, funding or strategy and are not automatically treatment failures.
Milestones to investigate
The table is ordered by reported primary completion date. Check whether the registry calls enrollment estimated or actual, when the record was last updated, and whether results have been published. Completion dates are not readout dates; no model-generated success probabilities are assigned.
For late-stage studies, choose PHASE3 above. For studies still underway, choose an exact recruitment status. Use sponsor and country filters to inspect a programme, then save records to compare their designs.
Matching trial records
| Trial | Sponsor and phase | Status | Enrollment | Start / primary completion / completion | Research workflow |
|---|---|---|---|---|---|
| Recall of Experience and Conscious Awareness in Psilocybin Treatment of Depression (The RECAP Study): Pilot Phase in Healthy Adult VolunteersPsychedelic Experiences · Amnesia | University of Wisconsin, Madison PHASE1 | Completed Registry updated 2023-05-19 | 8 ACTUAL | 2021-05-21 2022-11-17 2022-11-17 | |
| Mood and Cognitive Effects of Low Doses of Psilocybin Observed in Healthy Subjects ("MELO"): A Blinded, Placebo-Controlled, Dose-Finding StudyMood Disturbance · Mood Change · Sleep Disturbance · Drug Effect · Psychedelic Experiences · Health, Subjective · Psilocin Toxicity · Psilocybin Toxicity · Psilocybin Causing Adverse Effects in Therapeutic Use · Anxiety | Optimi Health Corporation EARLY_PHASE1 | Withdrawn Registry updated 2023-03-20 | 0 ACTUAL | 2023-01 2023-08 2023-12 | |
| Visual Surround Suppression and Perceptual Expectation Under PsilocybinPerception Disturbance · Visual Suppression · Psychedelic Experiences | University of Minnesota PHASE1 | Terminated Registry updated 2025-06-27 | 10 ACTUAL | 2021-08-30 2023-09-01 2023-09-01 | |
| Consciousness and Psilocybin Effects on Well-Being (The CoPE Study): Pilot PhaseHealthy · Psychedelic Experiences · Sleep | University of Wisconsin, Madison PHASE1 | Completed Registry updated 2025-05-16 | 6 ACTUAL | 2023-11-07 2025-02-19 2025-02-19 | |
| The Effects of Psilocybin on Shared Experience in Film ProcessingDisorders of Consciousness · Psychedelic Experiences | Western University, Canada NA | Unknown status Registry updated 2024-09-27 | 30 ESTIMATED | 2024-11 2025-09 2025-09 | |
| Multivariate Neural and Physiological Correlates of Psychedelic Sub-states: a Within-subjects, Healthy Volunteer Study With Experience-samplingPsychedelic Experiences · Neuroimaging · Healthy Volunteers | Robin Carhart-Harris, PhD, MA PHASE1 | Active, not recruiting Registry updated 2026-06-05 | 12 ESTIMATED | 2023-07-31 2026-01-30 2027-01-30 | |
| Safety for Home Administration of Microdose Psilocybin UsePsychedelic Experiences | Johns Hopkins University PHASE1 | Completed Registry updated 2026-08-14 | 17 ACTUAL | 2024-12-06 2026-07-31 2026-07-31 | |
| Activating Neuroplasticity to ENHANCE the Perception Box Expanding Effects of PsilocybinHealthy · Psychedelic Experiences · Vagus Nerve Stimulation | University of Wisconsin, Madison PHASE1 | Recruiting Registry updated 2026-10-20 | 115 ESTIMATED | 2025-01-27 2027-11 2028-01 | |
| Consciousness and Psilocybin Effects on Well-Being: The CoPEWell StudyWell-Being, Psychological · Psychedelic Experiences | University of Wisconsin, Madison PHASE1 | Not yet recruiting Registry updated 2026-10-30 | 120 ESTIMATED | 2027-02 2028-06 2028-06 |
Reported research facilities
5510 Nathan Shock DriveBaltimore, Maryland, United States · Coordinates available
UWHealth, 600 Highland AvenueMadison, Wisconsin, United States · Coordinates available
University of California, San FranciscoSan Francisco, California, United States · Coordinates available
University of MinnesotaMinneapolis, Minnesota, United States · Coordinates available
University of WisconsinMadison, Wisconsin, United States · Coordinates available
University of Wisconsin - MadisonMadison, Wisconsin, United States · Coordinates available
University of Wisconsin Hospital and ClinicsMadison, Wisconsin, United States · Coordinates available
This directory includes reported facilities with and without coordinates. For a country-filtered view, locations are labeled as selected-country sites or international sites of matching trials. Facilities are registry-reported trial sites, not an independently verified clinic or research-centre directory. Current services and contact details must be checked at the source.